Everest to acquire Singapore unit of Hasten Bio in $250M deal - BioWorld News
HealthcareDivestiture
Everest Medicines→Hasten Biopharmaceuticals Asia
Apr 9, 2026
Everest Medicines — Acquisitions & M&A Deals
1 dealTracking 1 M&A deal by Everest Medicines.